Phillip Esformes, the alleged mastermind of one of “the largest single criminal health care fraud cases ever brought against individuals by the Department of Justice,”has finally reached a plea deal with the Department of...more
3/22/2024
/ Anti-Kickback Statute ,
Assisted Living Facilities (ALFs) ,
Bribery ,
Department of Justice (DOJ) ,
Healthcare ,
Healthcare Fraud ,
Long Term Care Facilities ,
Nursing Homes ,
Patient Referrals ,
Plea Agreements ,
Senior Housing ,
Skilled Nursing Facility ,
Stark Law
On February 13, the U.S. Attorney’s Office (USAO) for the Southern District of New York (SDNY) announced a pilot program through which whistleblowers who voluntarily self-disclose criminal conduct relating to public or...more
The Department of Justice’s (DOJ) conduct since announcing its February 22, 2023, Voluntary Self Disclosure (VSD) policy, demonstrates that the government continues to place a premium on corporate cooperation in both criminal...more
On January 18, the Department of Justice (DOJ) joined the multistate attorneys general (AG) lawsuit Ohio, et al. v. NCAA, challenging the National Collegiate Athletic Association’s (NCAA) Transfer Eligibility Rule. DOJ joins...more
2/1/2024
/ Anti-Competitive ,
Antitrust Division ,
Antitrust Litigation ,
College Athletes ,
Colleges ,
Department of Justice (DOJ) ,
NCAA ,
Sports ,
State Attorneys General ,
Students ,
Transfer Restrictions
On February 22, 2023, the Department of Justice (DOJ) issued a press release highlighting the new Voluntary Self-Disclosure (VSD) Policy for U.S. Attorney’s Offices (USAOs). The DOJ developed this policy, which is applicable...more
4/28/2023
/ Centers for Medicare & Medicaid Services (CMS) ,
Cooperative Compliance Regime ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
Health Care Providers ,
Healthcare ,
Healthcare Facilities ,
Healthcare Fraud ,
OIG ,
Self-Disclosure Requirements ,
Voluntary Disclosure ,
White Collar Crimes
Nursing homes have come under fire recently for allegations of poor quality of service and patient safety concerns. So, it should come as no surprise that the Department of Health and Human Services (HHS) and state attorneys...more
Two recent cases suggest that the Department of Justice (DOJ) may be more open to deferred prosecution agreements (DPAs) as a vehicle to resolve False Claims Act (FCA) suits. Just recently on January 4, the U.S. Attorney’s...more
Introduction -
The U.S. Department of Justice (DOJ) has committed to aggressively investigate and prosecute COVID-19-related fraud schemes, particularly those involving government funding programs created or broadened...more
Join Troutman Pepper White Collar and Government Investigation Partners Callan Stein, Miranda Hooker, and Allison DeLaurentis for a podcast discussion on the DOJ’s updated guidelines regarding corporate criminal enforcement....more
9/27/2022
/ Compliance Monitoring ,
Corporate Crimes ,
Corporate Culture ,
Criminal Prosecution ,
Department of Justice (DOJ) ,
Enforcement ,
Individual Accountability ,
Internal Controls ,
New Guidance ,
Policies and Procedures ,
Risk Mitigation ,
Self-Disclosure Requirements ,
White Collar Crimes
The initiation of a government investigation is often a stressful and anxiety-producing event for a health care company. The Department of Justice (DOJ) is known for its aggressive investigation and prosecution of health care...more
9/9/2019
/ Civil Liability ,
Compliance Management Systems ,
Cooperative Compliance Regime ,
Criminal Prosecution ,
Department of Justice (DOJ) ,
Enforcement Actions ,
False Claims Act (FCA) ,
Fraud and Abuse ,
Government Investigations ,
Health Care Providers ,
Healthcare Fraud ,
Internal Controls ,
Third-Party ,
Whistleblowers
In July, The Washington Post published data showing approximately 76 billion oxycodone and hydrocodone pills were purchased and sold in the Unites States from 2006 to 2012. The data came from the Automation of Reports and...more
8/24/2019
/ Attorney-Client Privilege ,
Controlled Substances ,
Criminal Investigations ,
Data Management ,
DEA ,
Department of Justice (DOJ) ,
Drug & Alcohol Abuse ,
Drug Distribution ,
Failure to Comply ,
Government Investigations ,
Opioid ,
Pain Management ,
Pharmaceutical Industry ,
Prescription Drugs ,
Public Health ,
Reputation Management ,
Substance Abuse
On April 30, the Criminal Division of the Department of Justice released an update to the Fraud Section’s February 2017 guidance document titled “Evaluation of Corporate Compliance Programs.” ...more
On April 23, federal prosecutors announced the first-ever felony charges against a drug distributor — Rochester Drug Co-Operative, Inc. (RDC) — and two of its executives for illegally distributing opioid painkillers....more
5/10/2019
/ Controlled Substances Act ,
Criminal Prosecution ,
Department of Justice (DOJ) ,
Enforcement Actions ,
Felonies ,
Life Sciences ,
Opioid ,
Pain Management ,
Pharmaceutical Industry ,
Prescription Drugs ,
White Collar Crimes
On March 25, the U.S. Department of Justice (DOJ) announced that Duke University agreed to settle a False Claims Act qui tam action alleging widespread misconduct in federally funded research. ...more
4/3/2019
/ Department of Justice (DOJ) ,
Environmental Protection Agency (EPA) ,
False Claims Act (FCA) ,
Falsified Documents ,
Federal Funding ,
Grants ,
Medical Research ,
National Institute of Health (NIH) ,
Pharmaceutical Industry ,
Qui Tam ,
Settlement Agreements ,
Universities ,
Whistleblowers